When.com Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Ardelyx (ARDX) Upgraded to Buy: What Does It Mean for the Stock?

    www.aol.com/news/ardelyx-ardx-upgraded-buy-does...

    Ardelyx (ARDX) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

  3. Ardelyx (ARDX) Stock Jumps 6.8%: Will It Continue to Soar? - AOL

    www.aol.com/news/ardelyx-ardx-stock-jumps-6...

    Ardelyx (ARDX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more ...

  4. Prediction: These 2 Stocks Will Split in 2025 - AOL

    www.aol.com/prediction-2-stocks-split-2025...

    Netflix previously executed two stock splits: one in February 2004, 2-for-1, and another one in July 2015, a 7-for-1 stock split at around $700. The current price is much higher, so a 2025 stock ...

  5. 5 Predictions for the Stock Market in 2025 -- and Which ... - AOL

    www.aol.com/5-predictions-stock-market-2025...

    Nearly one year ago, I made four predictions about the stock market in 2024.I thought the S&P 500 would generate positive returns but lower than in 2023. I didn't believe the so-called ...

  6. Were Hedge Funds Right About Ardelyx Inc (ARDX)? - AOL

    www.aol.com/news/were-hedge-funds-ardelyx-inc...

    Need help? Call us! 800-290-4726 Login / Join. Mail

  7. Why Ardelyx Shares Are Sinking Today - AOL

    www.aol.com/news/why-ardelyx-shares-sinking...

    For premium support please call: 800-290-4726 more ways to reach us

  8. Did Ardelyx, Inc. (NASDAQ:ARDX) Insiders Buy Up More Shares?

    www.aol.com/news/did-ardelyx-inc-nasdaq-ardx...

    For premium support please call: 800-290-4726 more ways to reach us

  9. Ardelyx Stock Collapses After FDA Rejects Its Kidney Disease ...

    www.aol.com/ardelyx-stock-collapses-fda-rejects...

    Three months after revealing that the FDA had asked for more information to support tenapanor application for a chronic kidney disease drug, the FDA issued a letter to Ardelyx Inc (NASDAQ: ARDX ...